ABOUT US

Empowering Science with Precision and Simplicity!

Company profile

Company Culture

R&D Strength

News

Revolutionizing Drug Discovery: Yeast Two-Hybrid Screening in Pharmaceutical Industry

Release time:

2024-01-18

1. In the ever-evolving field of pharmaceutical research, scientists are constantly seeking innovative methods to accelerate the drug discovery process. Among these advancements, yeast two hybrid screen has emerged as a game-changer. This article explores the fascinating world of Yeast Two-Hybrid Screening and its potential to revolutionize drug discovery.
2. What is Yeast Two-Hybrid Screening?
Yeast two hybrid screen is a powerful technique used to study protein-protein interactions. It serves as a valuable tool for understanding the complex network of interactions that occur within cells and plays a vital role in drug discovery. By identifying and characterizing these interactions, researchers gain crucial insights into the mechanisms of diseases and potential targets for therapeutic intervention.
3. The Process of Yeast Two-Hybrid Screening
The yeast two hybrid screen process involves two key components: the bait and the prey. The bait protein, typically a known protein of interest, is fused with a DNA-binding domain. The prey protein library, consisting of thousands of potential interacting proteins, is fused with an activation domain. These fusion proteins are introduced into yeast cells, where the bait and prey proteins can interact. If an interaction occurs, it activates a reporter gene, leading to the production of a visible marker. This signal indicates a successful protein-protein interaction and helps researchers identify potential drug targets.
4. Benefits of Yeast Two-Hybrid Screening in Drug Discovery
Yeast two hybrid screen offers numerous advantages over traditional methods of studying protein-protein interactions. Firstly, it allows researchers to investigate interactions in a high-throughput manner, screening thousands of potential interactions simultaneously. This saves time and resources compared to traditional one-on-one interaction studies. Additionally, the technique is highly sensitive, and capable of detecting even weak or transient protein-protein interactions that may be missed by other methods. This sensitivity enhances the chances of identifying novel drug targets and potential therapeutic candidates.
5. Applications of Yeast Two-Hybrid Screening in Pharmaceutical Research
The applications of yeast two hybrid screen in pharmaceutical research are vast. This technique has been successfully employed in target identification and validation, lead compound screening, and drug repurposing. By elucidating protein-protein interactions associated with specific diseases, scientists can identify novel targets for drug development and design more effective therapeutic strategies. Yeast Two-Hybrid Screening also plays a crucial role in understanding drug resistance mechanisms, enabling the development of strategies to overcome resistance and improve treatment outcomes.
6. Challenges and Limitations of Yeast Two-Hybrid Screening
While Yeast Two-Hybrid Screening holds immense potential, it is not without its challenges and limitations. False positives and false negatives are common, requiring careful validation of identified interactions. The technique may also miss certain types of protein interactions or interactions occurring in specific cellular contexts. Additionally, the technology relies on the yeast model system, which may not fully represent human cellular processes. Despite these limitations, Yeast Two-Hybrid Screening remains a valuable tool in the drug discovery process.
7. Future Perspectives of Yeast Two-Hybrid Screening in the Pharmaceutical Industry
The future of yeast two hybrid screen in the pharmaceutical industry is promising. Advancements in technology, such as the development of more sophisticated reporter systems and improved screening platforms, continue to enhance the technique's capabilities. Furthermore, integration with other high-throughput screening methods, such as mass spectrometry and computational modeling, holds the potential for even greater discoveries. As researchers refine and expand upon the applications of Yeast Two-Hybrid Screening, it will undoubtedly contribute to the accelerated development of novel therapeutics.
8. yeast two hybrid screen is revolutionizing the field of drug discovery in the pharmaceutical industry. By enabling the study of protein-protein interactions on a large scale, this technique offers invaluable insights into disease mechanisms and potential therapeutic targets. The benefits of Yeast Two-Hybrid Screening, coupled with its ongoing advancements, ensure its place as a powerful tool in the quest for new and improved drugs. As the pharmaceutical industry continues to evolve, this technique will undoubtedly play a vital role in shaping its future.

Related News

2025-07-16

Literature Sharing | Interaction of PsMYB4 with PsEGL3 inhibits anthocyanin biosynthesis in tree peony yellow flowers

This study explores the molecular mechanism behind yellow flower formation in tree peony, a highly valued ornamental plant in China. Researchers identified two transcription factors, PsMYB4 and PsEGL3, that are highly expressed in a yellow-flowered cultivar.

2025-07-10

Literature Sharing | Putative Upstream Regulators DoNF-YB3 and DoIDD12 Correlate with DoGSTF11 Expression and Anthocyanin Accumulation in Dendrobium officinale

This study explores the role of the DoGSTF11 gene in Dendrobium officinale, a traditional medicinal herb. While previous research has focused on polysaccharides and alkaloids, this work addresses the lesser-known anthocyanin pathway. The researchers found that DoGSTF11 is highly expressed in the purplish variety of D. officinale and is localized in the nucleus and cell membrane, though it lacks transcriptional activation ability. Overexpressing DoGSTF11 in tomato led to increased anthocyanin accumulation, suggesting it plays a role in anthocyanin transport or sequestration. Protein interaction studies revealed that DoGSTF11 interacts with DoGST31, and that DoIDD12 and DoNF-YB3 may regulate its expression. Overall, the findings highlight DoGSTF11 as a positive regulator of anthocyanin accumulation and offer new insights for flavonoid metabolic engineering in D. officinale.

2025-07-08

Literature Sharing | Chinese cabbage orphan gene BR3 confers bolting resistance to Arabidopsis through the gibberellin pathway

Premature bolting affects yield and quality in Chinese cabbage, highlighting the importance of identifying bolting resistance genes. This study identifies an orphan gene, BR3 (BOLTING RESISTANCE 3), in Arabidopsis thaliana as a positive regulator of bolting resistance. BR3 is expressed during the seedling and flowering stages and localizes to the plasma membrane and nucleus. Overexpression of BR3 (BR3OE) delays bolting and flowering under both long-day and short-day conditions, with increased rosette leaf number and reduced plant height. Key flowering genes are downregulated in BR3OE plants. GA₃ treatment induces early flowering in both BR3OE and wild type (WT) plants, but BR3OE still flowers later than WT. In Chinese cabbage, BR3 shows co-expression with DELLA genes BrRGA1 and BrRGL3, suggesting a regulatory role through the GA pathway. This study offers new insights into bolting resistance mechanisms and provides valuable targets for breeding bolting-resistant Chinese cabbage varieties.

2025-07-03

Literature Sharing | Regulation of co-translational mRNA decay by PAP and DXO1 in Arabidopsis

This study investigates the regulation of the co-translational mRNA decay (CTRD) pathway in Arabidopsis, a critical mechanism for maintaining mRNA homeostasis. The researchers found that 3ʹ-phosphoadenosine 5ʹ-phosphate (PAP), an inhibitor of exoribonucleases, affects CTRD activity. Specifically, they showed that loss of FRY1 impairs XRN4-dependent CTRD and that exogenous PAP treatment stabilizes CTRD target mRNAs. Additionally, they discovered that another PAP-sensitive exoribonuclease, DXO1, also contributes to CTRD, likely by acting on NAD⁺-capped mRNAs involved in stress responses. These findings reveal new layers of regulation and additional players in the CTRD pathway in plants.

2025-07-01

Literature Sharing | Two pathogen-inducible UDP-glycosyltransferases, UGT73C3 and UGT73C4, catalyze the glycosylation of pinoresinol to promote plant immunity in Arabidopsis

This study uncovers a novel immune regulatory pathway in Arabidopsis thaliana involving two UDP-glycosyltransferases, UGT73C3 and UGT73C4, which are highly induced by Pseudomonas syringae infection. Overexpression of these genes enhances disease resistance, while their double mutation compromises immunity. Metabolomic analysis and biochemical assays reveal that UGT73C3/C4 glycosylate pinoresinol into its mono- and diglucoside forms, which promote immune responses by boosting ROS production and callose deposition. Additionally, the transcription factor HB34 directly activates UGT73C3/C4 expression, linking transcriptional regulation to glycosylation-mediated immunity. This work highlights the physiological significance of UGTs in plant defense through pinoresinol glycosylation.

2025-06-27

Literature Sharing | PbARP1 enhances salt tolerance of ‘Duli’ pear (Pyrus betulifolia Bunge) through abscisic acid signalling pathway

This study investigates salt stress tolerance in pears and identifies 35 salt-tolerant genes using a yeast expression library. Among them, PbARP1 was found to be significantly upregulated under salt stress in 'Duli' pear (Pyrus betulaefolia). Functional analyses showed that overexpression of PbARP1 in transgenic pear calli enhanced salt tolerance, while its suppression increased sensitivity to salt stress. Silencing PbARP1 also altered the expression of key ABA signaling genes, including PbPYL4, PbPYL9, PbPYL8, PbSRK2I, and PbABI5, suggesting that PbARP1 modulates salt stress responses through the ABA signaling pathway. Furthermore, PbPYL8, an ABA receptor, was identified as a protein interacting with PbARP1, highlighting its pivotal role in ABA-mediated salt stress regulation in pear.

2025-06-24

Literature Sharing | Phosphorylation of the strawberry MADS-box CMB1 regulates ripening via the catabolism of abscisic acid

This study uncovers a regulatory mechanism linking transcriptional control and posttranslational modification in strawberry fruit ripening. The MADS-box transcription factor FaCMB1 acts as a negative regulator of ripening, with both its transcript and protein levels decreasing during fruit development, a process enhanced by ABA. Functional manipulation of FaCMB1 significantly affected ripening and ABA content.

2025-06-20

Literature Sharing | Overexpression of soybean flavonoid 3′-hydroxylase enhances plant salt tolerance by promoting ascorbic acid biosynthesis

This study reveals that the flavonoid 3′-hydroxylase gene GmF3′H plays a key role in enhancing salt tolerance in soybean by regulating redox homeostasis. Using CRISPR/Cas9 knockout and overexpression approaches, the researchers demonstrated that GmF3′H competitively interacts with CSN5B, disrupting its binding to VTC1, a key enzyme in ascorbic acid biosynthesis. This redirection of metabolic flux toward the L-galactose pathway leads to increased ascorbic acid (AsA) levels, enhancing ROS scavenging capacity and improving salt stress tolerance during seed germination and seedling growth.

Do you have a question for us?

contact our experts

Explore More →

Tel: +86 025-85205672

Email: info@pronetbio.com

Address: Building 3C, Nanjing Xianlin Zhigu,

Qixia District, Nanjing, Jiangsu, China, 210033

Subscribe newsletter

Business license

Need more info?

Let's connect!

Any question? Get in touch with us!